Work

Acceptability of Intravaginal Artesunate as Adjuvant Therapy for Cervical Precancer and Persistent Human Papillomavirus: Data From a Phase 2 Placebo-Controlled Trial [ID 269]

Year: 2026

Type: article

Source: Obstetrics and Gynecology

DOI: 10.1097/aog.0000000000006265.04

Authors: Annum Sadana, Brenda Misiko, Felix Adundo, Chemtai Irene Mungo

Institution: New York University

Language: English

Topic: Cervical Cancer and HPV Research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160070846

FWCI:

Cites:

Cited by:

Related to: